Written By Lexx Thornton The first aceclidine- based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration (FDA) and will be available within three months. Known as VIZZ, from pharmaceutical company LENZ, the drops are an aceclidine ophthalmic solution that effectively treats presbyopia in adults. The once-daily drops offer relief from blurry vision for up to 10 hours. “The FDA approval of VIZZ is a defining moment for LENZ and represents a transformative improvement in the available treatment options
The post FDA’s Breakthrough Eye Drops appeared first on HBCU News.
